インスリンペンの世界市場2019-2023

◆英語タイトル:Global Insulin Pens Market 2019-2023
◆商品コード:IRTNTR30172
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年11月12日
◆ページ数:107
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、インスリンペンの世界市場について調査・分析し、市場概要、市場環境、インスリンペン市場規模、用途別(再利用可能型、使い捨て型)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・インスリンペンの世界市場概要
・インスリンペンの世界市場環境
・インスリンペンの世界市場動向
・インスリンペンの世界市場規模
・インスリンペンの世界市場:業界構造分析
・インスリンペンの世界市場:用途別(再利用可能型、使い捨て型)
・インスリンペンの世界市場:地域別市場規模・分析
・インスリンペンの北米市場規模・予測
・インスリンペンのヨーロッパ・中東・アフリカ市場規模・予測
・インスリンペンのアジア太平洋市場規模・予測
・インスリンペンの主要国分析
・インスリンペンの世界市場:意思決定フレームワーク
・インスリンペンの世界市場:成長要因、課題
・インスリンペンの世界市場:競争環境
・インスリンペンの世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、BD、Eli Lilly、Novo Nordisk、Sanofiなどです。
【レポートの概要】

About this market
The increasing focus on development of smart insulin pens for type 2 diabetes is likely to drive growth in the market. Companies are striving to grow in the market by incorporating advanced technologies into their products and services. Technavio’s analysts have predicted that the insulin pens market will register a CAGR of close to 9% by 2023.
Market Overview
Prevalence of diabetes cases across the globe
Growing incidence of diabetes have increased the demand for insulin pens in the market.
Increasing product recalls
Product recalls pose as a biggest threat to the market. Regulatory bodies and companies recalling products can impact the sales and a company’s brand image.
For the detailed list of factors that will drive and challenge the growth of the insulin pens market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be concentrated and with the presence of few companies including BD and Eli Lilly the competitive environment is quite intense. Factors such as the increasing focus on development of smart insulin pens and the incidences of diabetes, will provide considerable growth opportunities to insulin pens manufactures. BD, Eli Lilly, Sanofi, and Novo Nordisk are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be concentrated. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Reusable insulin pens – Market size and forecast 2018-2023
• Disposable insulin pens – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Rising strategic partnerships to boost sales of insulin pens
• Increasing focus on smart insulin pens
• Growing presence of diabetes specialty centers
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• BD
• Eli Lilly
• Novo Nordisk
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Product – Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Reusable insulin pens – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Reusable insulin pens – Year-over-year growth 2019-2023 (%)
Exhibit 21: Disposable insulin pens – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Disposable insulin pens – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in Americas
Exhibit 30: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in EMEA
Exhibit 33: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in APAC
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Diabetes and prediabetes cases in the US in 2015
Exhibit 39: Percentage of adults with diabetes aged between 20 and 79 years old in Europe in 2015
Exhibit 40: Product launches and market impact analysis
Exhibit 41: Insulin pens recall
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Focus on strategic partnerships
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: BD – Vendor overview
Exhibit 50: BD – Business segments
Exhibit 51: BD – Organizational developments
Exhibit 52: BD – Geographic focus
Exhibit 53: BD – Segment focus
Exhibit 54: BD – Key offerings
Exhibit 55: Eli Lilly – Vendor overview
Exhibit 56: Eli Lilly – Business segments
Exhibit 57: Eli Lilly – Organizational developments
Exhibit 58: Eli Lilly – Geographic focus
Exhibit 59: Eli Lilly – Segment focus
Exhibit 60: Eli Lilly – Key offerings
Exhibit 61: Novo Nordisk – Vendor overview
Exhibit 62: Novo Nordisk – Business segments
Exhibit 63: Novo Nordisk – Organizational developments
Exhibit 64: Novo Nordisk– Geographic focus
Exhibit 65: Novo Nordisk – Segment focus
Exhibit 66: Novo Nordisk – Key offerings
Exhibit 67: Sanofi – Vendor overview
Exhibit 68: Sanofi – Business segments
Exhibit 69: Sanofi – Organizational developments
Exhibit 70: Sanofi – Geographic focus
Exhibit 71: Sanofi – Segment focus
Exhibit 72: Sanofi – Key offerings



【掲載企業】

BD、Eli Lilly、Novo Nordisk、Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[インスリンペンの世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆